Structure Therapeutics, Inc. Sponsored ADR share price logo

Structure Therapeutics, Inc. Sponsored ADR

NASDAQ: GPCR

Small Cap

$21.19

-0.74

(-3.37%)

as on

Structure Therapeutics, Inc. Sponsored ADR Stock Performance

as on October 24, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $21.13
    $21.97
    downward going graph

    0.28%

    Downside

    3.68%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $20.73
    $94.90
    downward going graph

    2.19%

    Downside

    347.85%

    Upside

    downward going graph

Structure Therapeutics, Inc. Sponsored ADR share price movements today

Previous Close
$21.93
Open
$21.73
Volume
859.2K
Market Cap
$1.6B
Day's Low - High
$21.13 - $21.97
52 Week Low - High
$20.73 - $94.90

Structure Therapeutics, Inc. Sponsored ADR Historical Returns

1 Month Return
-41.17 %
3 Month Return
-56.86 %
1 Year Return
-19.7 %
3 Year Return
-69.18 %
5 Year Return
0 %

Structure Therapeutics, Inc. Sponsored ADR Stock Fundamentals & Key Indicators

Check Structure Therapeutics, Inc. Sponsored ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.6B

EPS (TTM)

-3.03

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-7.24

Industry PE ratio

-7.83

PEG Ratio

0.51

EBITDA

-212.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-16.91%

Structure Therapeutics, Inc. Sponsored ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Structure Therapeutics, Inc. Sponsored ADR with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$1.6BNA-7.240.00%0.00%
Neutral$80.9B-38.72%-25.39-12.57%0.00%
StrongBuy$43.5BNA26.4687.82%0.00%
StrongBuy$135.6B185.49%30.9086.04%0.00%
Buy$83.1B40.65%19.5684.86%0.46%

Stock Returns calculator for Structure Therapeutics, Inc. Sponsored ADR Stock including INR - Dollar returns

The Structure Therapeutics, Inc. Sponsored ADR stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Structure Therapeutics, Inc. Sponsored ADR investment value today

Current value as on today

₹86,408

Returns

-₹13,592

(-13.59%)

Returns from Structure Therapeutics, Inc. Sponsored ADR Stock

-₹19,704 (-19.7%)

Dollar Impact

₹6,112 (+6.11%)

Analyst Recommendation on Structure Therapeutics, Inc. Sponsored ADR Stock

Based on 9 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 9 analysts, 100% of analysts recommend a 'BUY' rating for Structure Therapeutics, Inc. Sponsored ADR. Average target price of $105.78

Structure Therapeutics, Inc. Sponsored ADR Share Price Target

Get share price movements and forecasts by analysts on Structure Therapeutics, Inc. Sponsored ADR.

What analysts predicted

79.97%UPSIDE

Target Price

$105.78

Current Price

$21.19

Analyzed by

9 Analysts

High

$145

Target

$105.78

Low

$70

Structure Therapeutics, Inc. Sponsored ADR target price $105.78, a slight upside of 79.97% compared to current price of $21.19. According to 9 analysts rating.

Indian Investors' Interest in Structure Therapeutics, Inc. Sponsored ADR Stock

Investment in Structure Therapeutics, Inc. Sponsored ADR Shares on INDmoney has grown by 1182.50% in the last 30 days, indicating increased investment activity.

Time period: to

Change:1182.50% versus previous 30 day period

Search interest for Structure Therapeutics, Inc. Sponsored ADR Stock has increased by 106% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:106% versus previous 30 day period

Structure Therapeutics, Inc. Sponsored ADR Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-1
-
Operating Income
-32
-33
-45
-47
-56
-70
-73
23
-89
-118
EBITDA
-25
-25
-33
-36
-46
-61
-65
33
-75
-105
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-26
-25
-33
-36
-46
-61
-65
33
-76
-105
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-26
-26
-33
-36
-46
-61
-65
33
-76
-106
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Structure Therapeutics, Inc. Sponsored ADR Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
0
-
-
-
-
-3
Operating Income
-15
-37
-52
-102
-158
-287
EBITDA
-15
-37
-51
-75
-121
-139
Interest Expense
-
0
-
13
-
-
Depreciation
0
0
0
0
0
1
Income Before Tax
-15
-37
-51
-89
-122
-140
Income Tax Expense
0
0
0
0
0
0
Net Income
-15
-40
-51
-89
-122
-141
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Structure Therapeutics, Inc. Sponsored ADR Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-26
-26
-33
-36
-46
-61
-65
33
-76
-106
Operating Cash Flow
-34
-26
-19
-36
-52
-54
-50
-64
15
-120
Investing Cash Flow
1
-204
-189
33
34
48
-49
56
-498
74
Financing Cash Flow
0
514
0
0
0
0
56
704
-1
2
Change in Cash
-31
283
-209
-2
-17
-5
-44
696
-483
-43

Structure Therapeutics, Inc. Sponsored ADR Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-15
-38
-51
-89
-122
-141
Operating Cash Flow
-14
-32
-46
-79
-116
-222
Investing Cash Flow
-21
17
-62
-268
-358
89
Financing Cash Flow
25
103
29
451
515
762
Change in Cash
-9
88
-79
103
39
630

Global Institutional Holdings in Structure Therapeutics, Inc. Sponsored ADR

Check out the Institutions with significant holdings in Structure Therapeutics, Inc. Sponsored ADR.

Funds
Holdings
VANGUARD SPECIALIZED FUNDS
4.08%
JANUS INVESTMENT FUND
2.26%
Steve Weber
2.18%
Felix Baker
2.01%
Fidelity Contrafund
1.88%

Structure Therapeutics, Inc. Sponsored ADR News & Key Events

  • img

    Today's Timeline - 08 September

    Tue, 06:06 PM

    -

    Structure Therapeutics reports positive trial results for ACCG-2671 and aleniglipron, showing significant weight loss and favorable safety profiles.

Insights on Structure Therapeutics, Inc. Sponsored ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 648.3% return, outperforming this stock by 668.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 163.4% return, outperforming this stock by 233.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, GPCR stock has moved down by -41.0%

About Structure Therapeutics, Inc. Sponsored ADR

Structure Therapeutics Inc., an international biopharmaceutical company currently in its clinical development phase, is committed to creating and providing groundbreaking oral therapies for various chronic diseases that lack adequate treatment options. The company's primary investigational drug, GSBR-1290, is an orally administered, biased small molecule agonist designed to target the glucagon-like-peptide-1 receptor (GLP-1R). This G-protein-coupled receptor (GPCR) is a recognized and validated therapeutic target for managing both type-2 diabetes mellitus and obesity. Furthermore, Structure Therapeutics is developing other oral small molecule treatments that act on different GPCRs, addressing pulmonary and cardiovascular conditions. For example, ANPA-0073 is a biased agonist aimed at the apelin receptor, a GPCR linked to diseases like idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension. Another compound in their pipeline is LTSE-2578, an oral small molecule that acts as a lysophosphatidic acid 1 receptor antagonist, also being explored for the treatment of IPF. Established in 2016, the company was formerly known as ShouTi Inc. and is headquartered in South San Francisco, California.
OrganisationStructure Therapeutics, Inc. Sponsored ADR
Headquarters611 Gateway Boulevard, South San Francisco, CA, 94080, US
IndustryBiotechnology
CEORaymond C. Stevens

Key Management of Structure Therapeutics, Inc. Sponsored ADR

Name

Title

Dr. Raymond C. Stevens Ph.D.

CEO & Director

Dr. Yingli Ma Ph.D.

Chief Technology Officer

Dr. Fang Zhang Ph.D.

Executive VP & Head of Biology

Dr. Hui Lei Ph.D.

Senior Vice President of Chemistry

Ms. Lani Ibarra

Senior Vice President of Clinical Development Operations

Mr. Jun S. Yoon

Co- Founder, CFO & Secretary

Dr. Xichen Lin Ph.D.

Chief Scientific Officer & GM of Structure Shanghai

Dr. Blai Coll M.D., Ph.D.

Chief Medical Officer

Mr. Matthew Lang J.D.

COO & General Counsel

Mr. Bob Gatmaitan

Senior Vice President of People

FAQs

What is Structure Therapeutics, Inc. Sponsored ADR share price today?

Structure Therapeutics, Inc. Sponsored ADR share price today is $21.19 as on at the close of the market. Structure Therapeutics, Inc. Sponsored ADR share today touched a day high of $21.97 and a low of $21.13.

What is the 52 week high and 52 week low for Structure Therapeutics, Inc. Sponsored ADR share?

Structure Therapeutics, Inc. Sponsored ADR share touched a 52 week high of $94.90 on and a 52 week low of $20.73 on . Structure Therapeutics, Inc. Sponsored ADR stock price today i.e. is closed at $21.19,which is 77.67% down from its 52 week high and 2.24% up from its 52 week low.

What is Structure Therapeutics, Inc. Sponsored ADR's market capitalisation today?

Structure Therapeutics, Inc. Sponsored ADR market capitalisation is $0.00T as on .

How to invest in Structure Therapeutics, Inc. Sponsored ADR Stock (GPCR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Structure Therapeutics, Inc. Sponsored ADR on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Structure Therapeutics, Inc. Sponsored ADR Stock (GPCR) from India?

Indian investors can start investing in Structure Therapeutics, Inc. Sponsored ADR (GPCR) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Structure Therapeutics, Inc. Sponsored ADR stock (as per the Rupee-Dollar exchange rate as on ). Based on Structure Therapeutics, Inc. Sponsored ADR share’s latest price of $21.19 as on October 24, 2026 at 8:46 am IST, you will get 0.4719 shares of Structure Therapeutics, Inc. Sponsored ADR. Learn more about fractional shares .